Dr. Suhas Singla

Director

Nuclear Medicine

MD - AIIMS Delhi, MBBS - UCMS and GTB Hospital

Medanta Noida

Book appointment

Select Month

September

October

Select Date

Mon

Tue

Wed

Thu

Fri

Sat

Mon

Tue

Wed

Thu

Fri

Sat

Mon

Tue

Wed

Thu

Fri

Sat

Mon

Tue

Wed

Thu

Fri

Sat

Mon

Book Appointment

About Dr. Suhas Singla

Pioneered 177Lu-DOTATATE therapy in India (2007)

Introduced 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida

Trained at AIIMS, New Delhi

Dr. Suhas Singla is a highly experienced nuclear medicine specialist with an MD in nuclear medicine from the All India Institute of Medical Sciences, Delhi. With expertise in both diagnostic and therapeutic applications, he is proficient in PET-CT, SPECT-CT, and targeted molecular therapies. He pioneered the initiation of 177Lu-DOTATATE therapy in India under the mentorship of Prof. C.S. Bal at AIIMS, Delhi, and later introduced both 177Lu-PSMA and 177Lu-DOTATATE therapies in Noida. With over 14 international publications, Dr. Singla combines innovation with evidence-based practice to deliver precision care for complex oncological conditions.

Pioneered 177Lu-DOTATATE therapy in India (2007)

Introduced 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida

Trained at AIIMS, New Delhi

Specialization And Expertise

Diagnostic oncoimaging with FDG, PSMA, DOPA, Choline, NOTA PET-CT

All SPECT-CT procedures

177Lu-DOTATATE therapy for unresectable neuroendocrine tumours

177Lu-PSMA therapy for advanced castrate-resistant prostate cancer